Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Hernia
Published in: Hernia 6/2021

Open Access 01-12-2021 | Botulinum Toxin | Review

A systematic review and meta-analysis of technical aspects and clinical outcomes of botulinum toxin prior to abdominal wall reconstruction

Authors: A. S. Timmer, J. J. M. Claessen, J. J. Atema, M. V. H. Rutten, R. Hompes, M. A. Boermeester

Published in: Hernia | Issue 6/2021

Login to get access

Abstract

Purpose

To systematically review technical aspects and treatment regimens of botulinum toxin A (BTA) injections in the lateral abdominal wall musculature. We also investigated the effect of BTA on abdominal muscle- and hernia dimensions, and clinical outcome.

Methods

PubMed, EMBASE, CENTRAL, and CINAHL were searched for studies that investigate the injection of BTA in the lateral abdominal wall muscles. Study characteristics, BTA treatment regimens, surgical procedures, and clinical outcomes are presented descriptively. The effect of BTA on muscle- and hernia dimensions is analyzed using random-effects meta-analyses, and exclusively for studies that investigate ventral incisional hernia patients.

Results

We identified 23 studies, comprising 995 patients. Generally, either 500 units of Dysport® or 200–300 units of Botox® are injected at 3–5 locations bilaterally in all three muscles of the lateral abdominal wall, about 4 weeks prior to surgery. No major procedural complications are reported. Meta-analyses show that BTA provides significant elongation of the lateral abdominal wall of 3.2 cm per side (95% CI 2.0–4.3, I2 = 0%, p < 0.001); 6.3 cm total elongation, and a significant but heterogeneous decrease in transverse hernia width (95% CI 0.2–6.8, I2 = 94%, p = 0.04). Furthermore, meta-analysis shows that BTA pretreatment in ventral hernia patients significantly increases the fascial closure rate [RR 1.08 (95% CI 1.02–1.16, I2 = 0%, p = 0.02)].

Conclusion

The injection technique and treatment regimens of botulinum toxin A as well as patient selection require standardization. Bilateral pretreatment in hernia patients significantly elongates the lateral abdominal wall muscles, making fascial closure during surgical hernia repair more likely.

Study registration

A review protocol for this meta-analysis was registered at PROSPERO (CRD42020198246).
Appendix
Available only for authorised users
Literature
1.
Millikan KW (2003) Incisional hernia repair. Surg Clin North Am 83(5):1223–1234CrossRef
2.
Cherla DV, Poulose B, Prabhu AS (2018) Epidemiology and disparities in care: the impact of socioeconomic status, gender, and race on the presentation, management, and outcomes of patients undergoing ventral hernia repair. Surg Clin North Am 98(3):431–440CrossRef
3.
Booth JH, Garvey PB, Baumann DP, Selber JC, Nguyen AT, Clemens MW et al (2013) Primary fascial closure with mesh reinforcement is superior to bridged mesh repair for abdominal wall reconstruction. J Am Coll Surg 217(6):999–1009CrossRef
4.
Holihan JL, Askenasy EP, Greenberg JA, Keith JN, Martindale RG, Roth JS et al (2016) Component separation vs. bridged repair for large ventral hernias: a multi-institutional risk-adjusted comparison, systematic review, and meta-analysis. Surg Infect (Larchmt) 17(1):17–26CrossRef
5.
Scheuerlein H, Thiessen A, Schug-Pass C, Kockerling F (2018) What do we know about component separation techniques for abdominal wall hernia repair? Front Surg 5:24CrossRef
6.
Jankovic J, Brin MF (1991) Therapeutic uses of botulinum toxin. N Engl J Med 324(17):1186–1194CrossRef
7.
Ibarra-Hurtado TR, Nuno-Guzman CM, Echeagaray-Herrera JE, Robles-Velez E, de Jesus G-J (2009) Use of botulinum toxin type a before abdominal wall hernia reconstruction. World J Surg 33(12):2553–2556CrossRef
8.
Deerenberg EB, Elhage SA, Raible RJ, Shao JM, Augenstein VA, Heniford BT et al (2020) Image-guided botulinum toxin injection in the lateral abdominal wall prior to abdominal wall reconstruction surgery: review of techniques and results. Skeletal Radiol 50:1–7CrossRef
9.
Soltanizadeh S, Helgstrand F, Jorgensen LN (2017) Botulinum toxin A as an adjunct to abdominal wall reconstruction for incisional hernia. Plast Reconstr Surg Glob Open 5(6):e1358CrossRef
10.
Weissler JM, Lanni MA, Tecce MG, Carney MJ, Shubinets V, Fischer JP (2017) Chemical component separation: a systematic review and meta-analysis of botulinum toxin for management of ventral hernia. J Plast Surg Hand Surg 51(5):366–374CrossRef
11.
Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 6(7):e1000097CrossRef
12.
Sterne JAC, Savovic J, Page MJ, Elbers RG, Blencowe NS, Boutron I et al (2019) RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ 366:l4898CrossRef
13.
14.
Zielinski MD, Kuntz M, Zhang X, Zagar AE, Khasawneh MA, Zendejas B et al (2016) Botulinum toxin A-induced paralysis of the lateral abdominal wall after damage-control laparotomy: a multi-institutional, prospective, randomized, placebo-controlled pilot study. J Trauma Acute Care Surg 80(2):237–242CrossRef
15.
Bueno-Lledo J, Martinez-Hoed J, Torregrosa-Gallud A, Menendez-Jimenez M, Pous-Serrano S (2020) Botulinum toxin to avoid component separation in midline large hernias. Surgery 168:543–549CrossRef
16.
Elstner KE, Read JW, Saunders J, Cosman PH, Rodriguez-Acevedo O, Jacombs ASW et al (2020) Selective muscle botulinum toxin A component paralysis in complex ventral hernia repair. Hernia 24(2):287–293CrossRef
17.
Zendejas B, Khasawneh MA, Srvantstyan B, Jenkins DH, Schiller HJ, Zielinski MD (2013) Outcomes of chemical component paralysis using botulinum toxin for incisional hernia repairs. World J Surg 37(12):2830–2837CrossRef
18.
Deerenberg EB, Shao JM, Elhage SA, Lopez R, Ayuso SA, Augenstein VA et al (2021) Preoperative botulinum toxin A injection in complex abdominal wall reconstruction—a propensity-scored matched study. Am J Surg 222:638–642CrossRef
19.
Blaha L, Chouliaras K, White A, McNatt S, Westcott C (2020) Intraoperative botulinum toxin chemodenervation and analgesia in abdominal wall reconstruction. Surg Innov 1–8.
20.
Elstner KE, Read JW, Rodriguez-Acevedo O, Cosman PH, Dardano AN, Jacombs AS et al (2017) Preoperative chemical component relaxation using Botulinum toxin A: enabling laparoscopic repair of complex ventral hernia. Surg Endosc 31(2):761–768CrossRef
21.
Farooque F, Jacombs AS, Roussos E, Read JW, Dardano AN, Edye M et al (2016) Preoperative abdominal muscle elongation with botulinum toxin A for complex incisional ventral hernia repair. ANZ J Surg 86(1–2):79–83CrossRef
22.
Ibarra-Hurtado TR, Nuno-Guzman CM, Miranda-Diaz AG, Troyo-Sanroman R, Navarro-Ibarra R, Bravo-Cuellar L (2014) Effect of botulinum toxin type A in lateral abdominal wall muscles thickness and length of patients with midline incisional hernia secondary to open abdomen management. Hernia 18(5):647–652CrossRef
23.
Palmisano EM, Mustone O, Santonja GP, Muas DJ, Blanco M (2020) Infiltración preoperatoria con toxina botulínica serotipo A en la reparación de hernias ventrales con defectos de tamaño de 10–15 cm: estudio multicéntrico. Rev Hispanoam Hernia 8(4):162–167
24.
Tang FX, Zong Z, Xu JB, Ma N, Zhou TC, Chen S (2020) Combination of preoperative progressive pneumoperitoneum and botulinum toxin A enables the laparoscopic transabdominal preperitoneal approach for repairing giant inguinoscrotal hernias. J Laparoendosc Adv Surg Tech A 30(3):260–266CrossRef
25.
Bueno-Lledo J, Carreno-Saenz O, Torregrosa-Gallud A, Pous-Serrano S (2020) Preoperative botulinum toxin and progressive pneumoperitoneum in loss of domain hernias-our first 100 cases. Front Surg 7:3CrossRef
26.
Catalan-Garza V, Pena-Soria MJ, Saez-Carlin P, Cabeza-Gomez JJ, Garcia-Fernandez A, Torres-Garcia AJ (2020) Long-term results of botulinum toxin type A in complex abdominal wall repair and review of the literature. Updates Surg 72:1201–1206CrossRef
27.
Chan DL, Ravindran P, Fan HS, Elstner KE, Jacombs ASW, Ibrahim N et al (2020) Minimally invasive Venetian blinds ventral hernia repair with botulinum toxin chemical component separation. ANZ J Surg 90(1–2):67–71CrossRef
28.
Chavez-Tostado K, Cárdenas-Lailson LE, Perez-Trigos H (2014) Results of preoperative application of botulinum toxin type A in treatment of giant incisional hernias. Rev Hispanoam Hernia 2:145–151CrossRef
29.
López AH, Rubalcava EJV (2016) Infiltración de toxina botulínica en la preparación preoperatoria de las hernias con defectos de 10 cm (y hasta 15 cm). Rev Hispanoam Hernia 4(2):43–49CrossRef
30.
Nielsen MO, Bjerg J, Dorfelt A, Jorgensen LN, Jensen KK (2020) Short-term safety of preoperative administration of botulinum toxin A for the treatment of large ventral hernia with loss of domain. Hernia 24(2):295–299CrossRef
31.
Yurtkap Y, van Rooijen MMJ, Roels S, Bosmans JML, Uyttebroek O, Lange JF et al (2020) Implementing preoperative botulinum toxin A and progressive pneumoperitoneum through the use of an algorithm in giant ventral hernia repair. Hernia 25:389–398CrossRef
32.
Zielinski MD, Goussous N, Schiller HJ, Jenkins D (2013) Chemical components separation with botulinum toxin A: a novel technique to improve primary fascial closure rates of the open abdomen. Hernia 17(1):101–107CrossRef
33.
Kohler G (2020) Preoperative conditioning and surgical strategies for treatment of complex abdominal wall hernias. Chirurg 91(2):134–142CrossRef
34.
Canario DAH, Isaacson AJ, Martissa JA, Stewart JK (2021) Ultrasound-guided chemical component separation with botulinum toxin A prior to surgical hernia repair. J Vasc Interv Radiol 32(2):256–261CrossRef
35.
Tashkandi A, Bueno-Lledo J, Durtette-Guzylack J, Cayeux A, Bukhari R, Rhaeim R et al. (2020) Adjunct botox to preoperative progressive pneumoperitoneum for incisional hernia with loss of domain: no additional effect but may improve outcomes. Hernia
36.
Tanaka EY, Yoo JH, Rodrigues AJ Jr, Utiyama EM, Birolini D, Rasslan S (2010) A computerized tomography scan method for calculating the hernia sac and abdominal cavity volume in complex large incisional hernia with loss of domain. Hernia 14(1):63–69CrossRef
37.
Wegdam JA, de Vries Reilingh TS, Bouvy ND, Nienhuijs SW (2020) Prehabilitation of complex ventral hernia patients with botulinum: a systematic review of the quantifiable effects of botulinum. Hernia
38.
Scaglione F (2016) Conversion ratio between Botox(R), Dysport(R), and Xeomin(R) in clinical practice. Toxins (Basel) 8(3):65CrossRef
Metadata
Title
A systematic review and meta-analysis of technical aspects and clinical outcomes of botulinum toxin prior to abdominal wall reconstruction
Authors
A. S. Timmer
J. J. M. Claessen
J. J. Atema
M. V. H. Rutten
R. Hompes
M. A. Boermeester
Publication date
01-12-2021
Publisher
Springer Paris
Published in
Hernia / Issue 6/2021
Print ISSN: 1265-4906
Electronic ISSN: 1248-9204
DOI
https://doi.org/10.1007/s10029-021-02499-1

Other articles of this Issue 6/2021

Hernia 6/2021 Go to the issue

Case Report

Robotic abdominoplasty for abdominal wall lateral bulging repair in an adult prune belly syndrome patient: a novel approach

Editor’s Corner

Trasversus abdomini release, botulinum, pneumoperitoneum: are they sufficient support in the treatment of complex incisional hernia?

Review

Prophylactic negative pressure wound therapy after open ventral hernia repair: a systematic review and meta-analysis

Letter to the Editor

The unsung heroes of hernia surgery

Review

Transversus abdominis release (TAR) for ventral hernia repair: open or robotic? Short-term outcomes from a systematic review with meta-analysis

Original Article

Component separation and large incisional hernia: predictive factors of recurrence